Proviten JR

Proviten JR is a sterile parenteral (intravenous) combination of essential vitamins and trace minerals intended for infants and children who cannot meet their nutritional micronutrient requirements through the oral or enteral route.

Established/Guideline-supported use

• As an additive to parenteral nutrition (PN) solutions to provide daily vitamin and trace mineral requirements in pediatric patients who are receiving total or partial parenteral nutrition (e.g., prematurity, extensive bowel resection, severe malabsorption syndromes, prolonged nil-by-mouth status after gastrointestinal surgery, chronic intestinal failure).
• As an adjunct to correct or prevent micronutrient (vitamin and trace element) deficiency in children who are unable to absorb or tolerate adequate oral/enteral intake of vitamins and minerals.

Not indicated for

• Routine oral nutritional supplementation in children who can tolerate enteral feeding — Proviten JR is a parenteral-route product only and is not a substitute for a balanced oral diet or oral multivitamin products.
• Adult use — this preparation is formulated and dosed specifically for the pediatric population.

Multivitamin and Multimineral [A-Z junior infusion preparation] is formulated as a sterile combination for intravenous use, typically supplied per single-dose vial/ampoule for addition to a parenteral nutrition admixture. Composition varies slightly by manufacturer but generally includes:

Vitamins

• Fat-soluble: Vitamin A, Vitamin D, Vitamin E, Vitamin K
• Water-soluble: Vitamin B1 (thiamine), Vitamin B2 (riboflavin), Vitamin B3 (niacinamide), Vitamin B5 (pantothenic acid), Vitamin B6 (pyridoxine), Vitamin B12 (cyanocobalamin), Vitamin C (ascorbic acid), Folic acid, Biotin

Trace minerals

• Zinc, Copper, Manganese, Selenium, and in some formulations Iodide and/or Chromium

The exact quantitative composition is age/weight-tiered (e.g., preterm infant, term infant/toddler, older child formulations) and should be confirmed against the specific product label and hospital pharmacy admixture protocol before use.

Proviten JR is a sterile, pyrogen-free parenteral preparation that combines multiple vitamins and trace minerals in a single formulation designed to be added to intravenous parenteral nutrition (PN) solutions for pediatric patients. It is used exclusively under the direction of, and administration by, qualified healthcare professionals in a hospital or supervised clinical setting.

It provides a convenient, single-additive way to supply daily micronutrient requirements to infants and children who depend wholly or partly on parenteral nutrition, reducing the number of separate additives required in the PN admixture.

Parenteral nutritional supplement — combined pediatric multivitamin and trace-mineral (multimineral) additive for intravenous infusion, used as an adjunct to parenteral nutrition. Proviten JR belongs to the class of parenteral micronutrient (vitamin and trace element) preparations.

Multivitamin and Multimineral [A-Z junior infusion preparation] supplies physiological quantities of vitamins and trace minerals directly into the systemic circulation, bypassing the gastrointestinal tract. This is particularly important in pediatric patients with malabsorption, short bowel syndrome, or an immature/non-functional gut, in whom enteral absorption of micronutrients cannot be relied upon.

• Vitamins act as essential cofactors and antioxidants in energy metabolism, growth, vision, coagulation, neurological function, and cellular repair.
• Trace minerals (zinc, copper, manganese, selenium, etc.) serve as cofactors for numerous metalloenzymes involved in growth, immune function, antioxidant defense, and connective tissue formation.

Because Multivitamin and Multimineral [A-Z junior infusion preparation] is administered intravenously, bioavailability is complete (100%), unlike oral vitamin/mineral products whose absorption can be variable, especially in children with gut dysfunction.

Proviten JR is for intravenous use only. It is added aseptically to the parenteral nutrition admixture by hospital pharmacy/trained staff and infused intravenously; it must never be given as an undiluted direct injection.

Clinically significant interactions relevant to Proviten JR include:

• Vitamin K component with oral anticoagulants (e.g., warfarin): may reduce anticoagulant effect; anticoagulant response should be monitored closely if Proviten JR is started, stopped, or dose-adjusted in a child receiving warfarin therapy.
• Calcium- or phosphate-containing infusates given via the same line (e.g., ceftriaxone, certain calcium salts): risk of precipitation/incompatibility; Proviten JR and its parenteral nutrition admixture should not be co-infused with drugs known to be physically or chemically incompatible in the same line.
• Other concurrent vitamin/mineral supplementation: concomitant oral or additional parenteral vitamin/trace element products may increase the risk of excess intake; total daily intake from all sources should be reviewed by the treating physician/pharmacist.

Reported adverse effects associated with Proviten JR include:

• Local infusion-site reactions — pain, irritation, phlebitis, or extravasation-related skin injury.
• Rare hypersensitivity/anaphylactoid reactions (e.g., rash, flushing, dyspnea) related to a formulation component.
• With prolonged parenteral use, biochemical vitamin or trace-element excess (e.g., manganese or copper accumulation, particularly in patients with hepatobiliary dysfunction) or, less commonly, deficiency if dosing is inadequate for clinical needs.

Proviten JR is a pediatric formulation and is not indicated for use in pregnant or lactating women; no pregnancy or lactation safety data are applicable to this product. Use in adolescents who are pregnant or breastfeeding should only occur under direct physician guidance, with an individualized risk-benefit assessment.

• Proviten JR must be administered only by, or under the direct supervision of, a qualified healthcare professional via appropriate intravenous access; it is not for home self-administration.
• Dosing must be individualized to the child's age and body weight, and should not exceed the recommended daily allowance for the pediatric age group without specific clinical justification.
• Monitor the infusion site regularly for signs of phlebitis, extravasation, or local reaction.
• With prolonged parenteral nutrition therapy, periodically monitor vitamin and trace element (especially manganese, copper, and selenium) status, particularly in patients with hepatic or renal impairment, in whom accumulation or altered clearance can occur.
• Protect the product from light where specified on the manufacturer's labeling, as certain vitamin components (e.g., vitamin A, riboflavin) are photosensitive.
• Confirm compatibility before co-administering with other intravenous medications in the same line (see Interactions).

Excessive or prolonged administration of Proviten JR beyond recommended pediatric requirements may lead to vitamin or trace-mineral toxicity (hypervitaminosis or mineral excess), with effects depending on which component accumulates. If overdose is suspected, discontinue the infusion and seek immediate medical attention; management is supportive and should be directed by a physician or, where appropriate, a poison control center, based on the specific components and degree of excess involved.

Store Proviten JR at room temperature (below 25–30°C as specified on the product label), protected from light, and do not freeze unless the manufacturer's labeling states otherwise. Once added to a parenteral nutrition admixture, use promptly according to hospital pharmacy stability and compatibility protocols. Keep out of reach of children.

• Preterm/low-birth-weight infants: dosing is weight-based and individualized; consult neonatal dosing protocols specific to the product.
• Infants and children (term to approximately 11 years/<40 kg): the pediatric-strength formulation of Proviten JR is intended for this group; dose per age-appropriate vial/unit.
• Adolescents ≥11 years or ≥40 kg: transition to an adult-strength parenteral multivitamin/multimineral preparation is generally appropriate, per physician judgment.
• Hepatic impairment: increased risk of manganese and copper accumulation; monitor levels and consider dose adjustment or temporary withholding of trace elements with prolonged use, per physician assessment.
• Renal impairment: selenium, chromium, and other trace elements may accumulate; monitor and adjust as clinically indicated.
• Elderly/adult use: not applicable — this is a pediatric-specific formulation.

The duration of treatment with Proviten JR is individualized and continues for as long as the child requires parenteral nutritional support and cannot meet micronutrient needs enterally. Nutritional status, growth, and biochemical parameters should be reassessed regularly by the treating team, with a transition to oral/enteral vitamin and mineral intake as gastrointestinal function and feeding tolerance allow.

Some presentations of Proviten JR are supplied as a lyophilized powder or concentrate that must be reconstituted or diluted with the appropriate sterile diluent (e.g., sterile water for injection or compatible parenteral nutrition base solution) prior to addition to the parenteral nutrition admixture. Reconstitution/dilution should be performed by hospital pharmacy or trained clinical staff using aseptic technique, strictly according to the specific product's manufacturer instructions, and the reconstituted solution should be inspected for particulate matter and discoloration before use.

Multivitamin and Multimineral [A-Z junior infusion preparation] belongs to the parenteral vitamin and trace-mineral (multimineral) combination class of nutritional supplement preparations, used specifically as an additive to pediatric parenteral nutrition regimens.

Multivitamin and Multimineral [A-Z junior infusion preparation] works by directly replenishing the body's essential vitamin and trace-mineral pools via the intravenous route, bypassing gastrointestinal absorption:

• Vitamins act as coenzymes/cofactors in carbohydrate, protein, and fat metabolism, and support antioxidant defense, vision, coagulation (vitamin K), bone mineralization (vitamin D), and neurological and hematologic function (B-complex vitamins).
• Trace minerals such as zinc, copper, manganese, and selenium function as catalytic or structural components of metalloenzymes essential for growth, wound healing, immune competence, and antioxidant enzyme systems (e.g., superoxide dismutase, glutathione peroxidase).

By supplying these micronutrients directly into the bloodstream, Multivitamin and Multimineral [A-Z junior infusion preparation] helps prevent or correct deficiency states in children who cannot obtain adequate amounts through oral or enteral intake.

Proviten JR is specifically formulated and dosed for pediatric patients — from preterm/low-birth-weight infants through children up to approximately 11 years of age or 40 kg body weight — who require vitamin and trace mineral supplementation via the parenteral route because they cannot meet these needs orally or enterally (e.g., during parenteral nutrition, after major gastrointestinal surgery, or with severe malabsorption). Dosing must always be individualized by age and weight under direct physician/pharmacist supervision; safety and dosing for children outside the labeled age/weight range have not been established for this pediatric-strength formulation.